Remove financials
article thumbnail

The financial toxicity of treating cancer

World of DTC Marketing

According to the study “financial hardship or “financial toxicity” is an increasingly recognized consequence of cancer treatment that results from high out-of-pocket medical costs (e.g., The post The financial toxicity of treating cancer. copayments and deductibles), nonmedical fees (e.g.,

article thumbnail

Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer

Pharma Mirror

In his new position, asChief Financial Officer (CFO) Peter Hackel will be responsible for Finance &Controlling, Foreign Trade and IT of Syntegon. followed by Geistlich Pharma AG, The post Syntegon Group appoints Dr. Peter Hackel as Chief Financial Officer appeared first on Pharma Mirror Magazine.

Packaging 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Role of Financial Management and GAAP in Clinical Research

ACRP blog

Visibility into and control of the financial aspects of a site’s research portfolio are key to building a successful financial site workflow. In this article, we will explore the importance of sound financial practices for sites. This makes it difficult to gain the visibility needed to make intelligent, data-driven decisions.

article thumbnail

Financial incentives & allocation of suitable plots for hospitals by govt to offset healthcare challenges

AuroBlog - Aurous Healthcare Clinical Trials blog

Challenges in the healthcare industry can be offset if the government takes several measures including land allotments for hospitals and introduce financial incentives and subsidies to healthcare providers to stimulate investments in infrastructure, medical technology, and workforce development, said Pritika Singh, CEO, Prayag Hospitals Group.

article thumbnail

How Financialization Has Impacted the US Healthcare System

Pharmaceutical Commerce

Experts explore ways in which the financial sector refined the healthcare landscape, including its evolutions throughout the years.

100
100
article thumbnail

Top 20 global M&A financial advisers for H1 2023 revealed

Pharmaceutical Technology

GlobalData has revealed the top 20 global M&A financial advisers for H1 2023 in its latest league tables.

130
130
article thumbnail

After transformation under new CEO, Leo Pharma touts innovation model and financial progress

Fierce Pharma

Taking over as CEO for an aging company in dire financial straits and in need of a slimdown was a challenging assignment for Christophe Bourdon. Taking over as CEO for an aging company in dire financial straits and in need of a slimdown was a challenging assignment for Christophe Bourdon.

68